EFPIA Newsletter 21 September 2017

#WeWontRest video

Blogs     21 September 2017 21092017 ISENTRESS: integrase strand transfer inhibitor active against HIV type 1 With over 7000 medicines in development, new treatments will continue to change patients’ lives; slowing disease progression,... Read more →         21 September 2017 21092017 Disease interception – What does it mean and why is it important? (Guest blog) As our scientific understanding increases, catching diseases earlier is becoming more and more likely. For many conditions,... Read more →

Events     02 OCT 2017   15 June 2017 First edition of the ‘Real-World Evidence in Medicine Development’ course... Online learning A course by GetReal Learn more →       25 OCT 2017   11 September 2017 2017 ICHOM Conference Washington, D.C. Join value-innovators from across the health care spectrum in Washington, D.C. Learn more →

	21 NOV 2017			19 July 2017 War on Cancer – a patient’s journey The HAC, London, UK 3rd annual conference organised by The Economist Events Learn more →

What we are reading World needs vigorous regulatory action to fight AMR 01 January 0001  (The Parliament Magazine) Read more →

About the EFPIA newsletter The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 36 national associations and 39 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55 Communications@efpia.eu ▶ in

EFPIA 2026 All rights reserved  ·  Disclaimer  ·  Unsubscribe